Information Provided By: 
Fly News Breaks for October 20, 2015
WMGI
Oct 20, 2015 | 07:26 EDT
After surveying 20 foot and ankle surgeons, Jefferies analyst Raj Denhoy pegs the annual market opportunity for Wright Medical's Augment at $75M, well below the company's target of $300M. Most viewed Augment's clinical and safety profile favorably, but it is considered more expensive than autograft and utilization will be limited to 25% of cases, Denhoy tells investors in a research note. The analyst lowered his forecasts for Augment "modestly" and keeps a Hold rating on Wright with a $25 price target.
News For WMGI From the Last 2 Days
There are no results for your query WMGI
